Voriconazole stability in cement spacers

Med Mal Infect. 2012 Nov;42(11):567-8. doi: 10.1016/j.medmal.2012.07.007. Epub 2012 Oct 6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacokinetics*
  • Antifungal Agents / therapeutic use
  • Arthroplasty, Replacement, Hip*
  • Biofilms* / drug effects
  • Bone Cements*
  • Candida glabrata / isolation & purification*
  • Candidiasis / drug therapy*
  • Candidiasis / etiology
  • Candidiasis / prevention & control
  • Caspofungin
  • Device Removal*
  • Dose-Response Relationship, Drug
  • Drug Implants
  • Drug Stability
  • Drug Therapy, Combination
  • Echinocandins / administration & dosage
  • Echinocandins / therapeutic use
  • Hip Prosthesis / adverse effects*
  • Hip Prosthesis / microbiology
  • Humans
  • Infusions, Intravenous
  • Lipopeptides
  • Male
  • Middle Aged
  • Prostheses and Implants*
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / surgery
  • Pyrimidines / administration & dosage
  • Pyrimidines / pharmacokinetics*
  • Pyrimidines / therapeutic use
  • Triazoles / administration & dosage
  • Triazoles / pharmacokinetics*
  • Triazoles / therapeutic use
  • Voriconazole

Substances

  • Antifungal Agents
  • Bone Cements
  • Drug Implants
  • Echinocandins
  • Lipopeptides
  • Pyrimidines
  • Triazoles
  • Caspofungin
  • Voriconazole